Sickle Cell Disease Clinical Trial
Official title:
Implication of the Oxydative Stress in the Pathophysiology of Sickle Cell Anemia: Vaso-occlusive Crises, Anti Bande 3 Antibodies Levels, Red Blood Cell Oxidation
Despite important advances in the current understanding of sickle cell vaso-occlusion, the basis of its control and prevention remain partially unknown. The primary purpose is to test the hypothesis of a control of the sickle cell vaso-cocclusive (VOC) process by the anti band 3 antibodies by assessing the level of these antibodies in the steady state and during the crises in SCA patients. To assess the relationship between the level of band 3 antibodies, the oxidation status, the expression of microparticles and the hemorheological alterations of the sickle red cells (SS RBs), the severity of VOC.
Although oxidative stress is not the primary aetiology of SCA, oxidative damage could in part
account for pathophysiological mechanisms leading to sickle vaso-occlusion, in which anti
bande 3 antibodies might play a role. Bande 3 is a protein belonging to red blood cells.
These anti bande 3 antibodies are producted when after oxidative damage, a hidden site of
bande 3 is revealed. In preliminary data, the Cuban partner of this study showed a
significative difference between their level in patients, during steady state and
vaso-occlusive crises. Our clinical question is to determine if a decrease of these
antibodies, could participate in the occurrence of the crises. Therapeutic strategies aimed
to counteract oxidative abnormalities might alleviate this still nowadays unknown mechanisms
disease progression.
Band 3 protein which belongs to the anionic interchanger is the main erythrocyte membrane
protein, present in about 1.2 x 106 copies per cell. Under certain conditions, band 3 protein
modifications in the human erythrocyte membrane surface lead to band 3 aggregates. These
modifications are mostly due to oxidative insults that gradually accumulate during red blood
cell lifespan. Band 3 clusters on the SS RBCs produce two significant changes: first, these
cells acquire an adhesive nature; second, band 3 aggregates are recognized by natural band 3
antibodies. Several studies have shown that band 3 peptides are able to inhibit the adherence
of SS RBCs to endothelial cells. This suggests possible participation of band 3 antibodies in
the aethiology as well as in the prevention of VOC in SCA. Oxidant damage in RBCs may
contribute to the circulatory disorders by affecting their flow properties i.e. their
deformability, aggregability and adherence to endothelial cells. Therefore, in parallel of
the study of the evaluation of the role of anti bande 3 antibodies in VOC occurrence and
severity, the investigators will explore the involvement of oxidative stress on the
rheological properties of SSRBCs (deformability and aggregability),
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02227472 -
Working Memory and School Readiness in Preschool-Aged Children With Sickle Cell Disease
|
||
Recruiting |
NCT06301893 -
Uganda Sickle Surveillance Study (US-3)
|
||
Recruiting |
NCT04398628 -
ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
|
||
Completed |
NCT02522104 -
Evaluation of the Impact of Renal Function on the Pharmacokinetics of SIKLOS ® (DARH)
|
Phase 4 | |
Recruiting |
NCT04688411 -
An mHealth Strategy to Improve Medication Adherence in Adolescents With Sickle Cell Disease
|
N/A | |
Terminated |
NCT03615924 -
Effect of Ticagrelor vs. Placebo in the Reduction of Vaso-occlusive Crises in Pediatric Patients With Sickle Cell Disease
|
Phase 3 | |
Not yet recruiting |
NCT06300723 -
Clinical Study of BRL-101 in Severe SCD
|
N/A | |
Recruiting |
NCT03937817 -
Collection of Human Biospecimens for Basic and Clinical Research Into Globin Variants
|
||
Completed |
NCT04134299 -
To Assess Safety, Tolerability and Physiological Effects on Structure and Function of AXA4010 in Subjects With Sickle Cell Disease
|
N/A | |
Completed |
NCT04917783 -
Health Literacy - Neurocognitive Screening in Pediatric SCD
|
N/A | |
Completed |
NCT02580565 -
Prevalence of Problematic Use of Equimolar Mixture of Oxygen and Nitrous Oxide and Analgesics in the Sickle-cell Disease
|
||
Recruiting |
NCT04754711 -
Interest of Nutritional Care of Children With Sickle Cell Disease on Bone Mineral Density and Body Composition
|
N/A | |
Completed |
NCT04388241 -
Preliminary Feasibility and Efficacy of Behavioral Intervention to Reduce Pain-Related Disability in Pediatric SCD
|
N/A | |
Recruiting |
NCT05431088 -
A Phase 2/3 Study in Adult and Pediatric Participants With SCD
|
Phase 2/Phase 3 | |
Completed |
NCT01158794 -
Genes Influencing Iron Overload State
|
||
Recruiting |
NCT03027258 -
Point-of-Delivery Prenatal Test Results Through mHealth to Improve Birth Outcome
|
N/A | |
Withdrawn |
NCT02960503 -
Macrolide Therapy to Improve Forced Expiratory Volume in 1 Second in Adults With Sickle Cell Disease
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT02525107 -
Prevention of Vaso-occlusive Painful Crisis by Using Omega-3 Fatty Acid Supplements
|
Phase 3 | |
Completed |
NCT02620488 -
A Brief Laboratory-Based Hypnosis Session for Pain in Sickle Cell Disease
|
N/A | |
Completed |
NCT02565082 -
Evaluation of the Hemostatic Potential in Sickle Cell Disease Patients
|
N/A |